Ovarian cancer

Evaluates the analytical and clinical
validity of BRCA1/2 genetic testing and discusses the ethical and psychosocial issues inherent in BRCA1/2 testing.

Describes the nature of the evidence concerning the use of this genetic technology and discusses the unresolved questions and uncertainties that complicate the decision-making process.

Provides a literature review with respect to: the prevalence of BRCA1/2 mutations in HBOC families, breast or ovarian cancer cases, and certain founder populations, the available risk assessment models, and more.

Discusses genetic testing for breast and ovarian cancer risk. Looks at management options for carriers.

Reviews the status of available screening tools, common ovarian cancer symptoms, and the elements of an appropriate examination.

Explores the experience of younger women, less than forty years old, who are diagnosed with ovarian cancer.

Explores common questions of women who have recently been diagnosed with ovarian cancer. Includes types of ovarian cancer, questions to ask healthcare professionals, treatment, and coping with illness.

Explores, in Punjabi, common questions of women who have recently been diagnosed with ovarian cancer. Includes types of ovarian cancer, questions to ask healthcare professionals, treatment, and coping with illness.

Explores, in Chinese, common questions of women who have recently been diagnosed with ovarian cancer. Includes types of ovarian cancer, questions to ask healthcare professionals, treatment, and coping with illness.

Provides an overview of ovarian cancer including risk factors, symptoms, and diagnosis.